Literature DB >> 24905786

Histone chaperones: assisting histone traffic and nucleosome dynamics.

Zachary A Gurard-Levin1, Jean-Pierre Quivy, Geneviève Almouzni.   

Abstract

The functional organization of eukaryotic DNA into chromatin uses histones as components of its building block, the nucleosome. Histone chaperones, which are proteins that escort histones throughout their cellular life, are key actors in all facets of histone metabolism; they regulate the supply and dynamics of histones at chromatin for its assembly and disassembly. Histone chaperones can also participate in the distribution of histone variants, thereby defining distinct chromatin landscapes of importance for genome function, stability, and cell identity. Here, we discuss our current knowledge of the known histone chaperones and their histone partners, focusing on histone H3 and its variants. We then place them into an escort network that distributes these histones in various deposition pathways. Through their distinct interfaces, we show how they affect dynamics during DNA replication, DNA damage, and transcription, and how they maintain genome integrity. Finally, we discuss the importance of histone chaperones during development and describe how misregulation of the histone flow can link to disease.

Keywords:  cancer; chromatin; epigenetics; genome function and instability

Mesh:

Substances:

Year:  2014        PMID: 24905786     DOI: 10.1146/annurev-biochem-060713-035536

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  133 in total

1.  Totipotency in the absence of CAF-I: unhindered choices when the chaperone is out.

Authors:  Krassimir Yankulov
Journal:  Nucleus       Date:  2015-12-28       Impact factor: 4.197

Review 2.  The right place at the right time: chaperoning core histone variants.

Authors:  Francesca Mattiroli; Sheena D'Arcy; Karolin Luger
Journal:  EMBO Rep       Date:  2015-10-12       Impact factor: 8.807

Review 3.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

4.  Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 Treatment.

Authors:  Gaëlle Palierne; Aurélie Fabre; Romain Solinhac; Christine Le Péron; Stéphane Avner; Françoise Lenfant; Coralie Fontaine; Gilles Salbert; Gilles Flouriot; Jean-François Arnal; Raphaël Métivier
Journal:  Mol Endocrinol       Date:  2016-05-10

5.  Epigenomics: Roadmap for regulation.

Authors:  Casey E Romanoski; Christopher K Glass; Hendrik G Stunnenberg; Laurence Wilson; Genevieve Almouzni
Journal:  Nature       Date:  2015-02-19       Impact factor: 49.962

Review 6.  Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes.

Authors:  Cedric R Clapier; Janet Iwasa; Bradley R Cairns; Craig L Peterson
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

7.  Mechanisms Underlying Acrolein-Mediated Inhibition of Chromatin Assembly.

Authors:  Lei Fang; Danqi Chen; Clinton Yu; Hongjie Li; Jason Brocato; Lan Huang; Chunyuan Jin
Journal:  Mol Cell Biol       Date:  2016-11-14       Impact factor: 4.272

Review 8.  Chaperone-mediated chromatin assembly and transcriptional regulation in Xenopus laevis.

Authors:  Takashi Onikubo; David Shechter
Journal:  Int J Dev Biol       Date:  2016       Impact factor: 2.203

9.  The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.

Authors:  Rocío Montes de Oca; Zachary A Gurard-Levin; Frédérique Berger; Haniya Rehman; Elise Martel; Armelle Corpet; Leanne de Koning; Isabelle Vassias; Laurence O W Wilson; Didier Meseure; Fabien Reyal; Alexia Savignoni; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal:  Mol Oncol       Date:  2014-11-20       Impact factor: 6.603

10.  Chromatin Regulators as a Guide for Cancer Treatment Choice.

Authors:  Zachary A Gurard-Levin; Laurence O W Wilson; Vera Pancaldi; Sophie Postel-Vinay; Fabricio G Sousa; Cecile Reyes; Elisabetta Marangoni; David Gentien; Alfonso Valencia; Yves Pommier; Paul Cottu; Geneviève Almouzni
Journal:  Mol Cancer Ther       Date:  2016-05-16       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.